EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baclofen Promotes Osteochondrogenic Commitment of Mesenchymal Stem Cells: Implications for Heterotopic Ossification Risk

María Crugeiras-Sampedro iD, Lorena Zas-Veiga iD, María Piñeiro-Ramil, Andrés Pazos-Pérez, Verónica López-López, Alberto Jorge-Mora iD, Ana Alonso-Pérez iD, Rodolfo Gómez iD

International Journal of Molecular Sciences · 19.03.2026 · 27 (6) · 2783

DOI: 10.3390/ijms27062783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.03.2026. Verfasst von María Crugeiras-Sampedro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Musculoskeletal Pathology Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago University Clinical Hospital, Servizo Galego de…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Ossification, Heterotopic, Baclofen, Osteogenesis. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Xunta de Galicia, Fundación Mutua Madrileña.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) Heterotopic ossification (HO) is a pathological process characterized by ectopic bone formation in soft tissues, often following trauma or neurological injury, and is associated with spasticity and chronic inflammation. Mesenchymal stem cells (MSCs) play a central role in HO by differentiating into osteoblasts through endochondral or intramembranous ossification, while alternative fates such as adipogenesis are suppressed. In this study, we investigated the effects of two commonly used antispastic drugs, baclofen and tizanidine, on MSC differentiation under adipogenic and inflammatory conditions in vitro. (2) Mouse C3H10T1/2 MSCs were cultured and induced toward adipogenesis in the presence of baclofen or tizanidine, and inflammatory stimuli (Interleukin-1β or lipopolysaccharides) were applied where indicated. Gene expressions of adipogenic and osteochondrogenic markers were assessed by RT-qPCR, while osteopontin protein levels were quantified by Simple Western. (3) Baclofen treatment significantly inhibited adipogenic gene expression and promoted osteochondrogenic markers and osteopontin protein under basal conditions, whereas tizanidine had minimal effects. Under inflammatory conditions, baclofen partially suppressed adipogenesis but did not strongly induce osteochondrogenesis. (4) These findings indicate that baclofen can directly modulate MSC fate, potentially contributing to HO risk, while tizanidine may offer a safer alternative for spasticity management in patients at risk of ectopic bone formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOssification, HeterotopicBaclofenOsteogenesisChondrogenesisAnimalsMiceAdipogenesisCell DifferentiationCell Line

Stichwörter der Autor:innen

adipogenesisbaclofenectopic bone formation and MSC differentiationheterotopic ossificationinflammationmesenchymal stem cellsosteochondrogenesisspasticitytizanidine

Substanzen

Baclofen

Autor:innen und Institutionen

  • Musculoskeletal Pathology Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago University Clinical Hospital, Servizo Galego de Saude (SERGAS), 15706 Santiago de Compostela, Spain.
  • Traumatology and Orthopedics Service, A Coruña University Clinical Hospital, Servizo Galego de Saude (SERGAS), 15006 A Coruña, Spain.

ORCID-Profile: María Crugeiras-Sampedro, Lorena Zas-Veiga, Alberto Jorge-Mora, Ana Alonso-Pérez, Rodolfo Gómez

Förderung

  • Instituto de Salud Carlos III
  • Xunta de Galicia
  • Fundación Mutua Madrileña
  • FUNDACION PUBLICA GALLEGA INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA
  • EUROPEAN COMMISSION
  • European Union
  • Mutua Madrileña Foundation
  • Instituto de Investigación Sanitaria de Santiago de Compostela

Zitieren

APA

Crugeiras-Sampedro, M., Zas-Veiga, L., Piñeiro-Ramil, M., Pazos-Pérez, A., López-López, V., Jorge-Mora, A., Alonso-Pérez, A., & Gómez, R. (2026). Baclofen Promotes Osteochondrogenic Commitment of Mesenchymal Stem Cells: Implications for Heterotopic Ossification Risk. International Journal of Molecular Sciences, 27(6), 2783. https://doi.org/10.3390/ijms27062783

Vancouver

Crugeiras-Sampedro M, Zas-Veiga L, Piñeiro-Ramil M, Pazos-Pérez A, López-López V, Jorge-Mora A, et al. Baclofen Promotes Osteochondrogenic Commitment of Mesenchymal Stem Cells: Implications for Heterotopic Ossification Risk. International Journal of Molecular Sciences. 2026;27(6):2783. doi:10.3390/ijms27062783

BibTeX
@article{CrugeirasSampedro2026,
  author = {Crugeiras-Sampedro, María and Zas-Veiga, Lorena and Piñeiro-Ramil, María and Pazos-Pérez, Andrés and López-López, Verónica and Jorge-Mora, Alberto and Alonso-Pérez, Ana and Gómez, Rodolfo},
  title = {Baclofen Promotes Osteochondrogenic Commitment of Mesenchymal Stem Cells: Implications for Heterotopic Ossification Risk},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2783},
  doi = {10.3390/ijms27062783}
}
Kostenlos starten →